Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
Root, Inc. (ROOT)


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-12-21 Malka Meyer 10%-Owner Sell 54,336 $4.80 $260,814 No
2021-11-15 Shah Hemal Chief Product Officer Sell 41,666 $5.12 $213,330 No
2021-06-01 Manges Daniel Chief Technology Officer Sell 150,000 $8.80 $1,320,000 Yes
2021-03-15 Manges Daniel Chief Technology Officer Sell 250,000 $11.04 $2,759,686 No
2021-03-15 Manges Daniel Chief Technology Officer Sell 250,000 $11.04 $2,759,686 No
2020-10-30 Manges Daniel Chief Technology Officer Buy 1,000 $27.00 $27,000 No
2020-12-30 Malka Meyer 10%-Owner Buy 753,976 $16.55 $12,477,184 No
2020-10-30 Malka Meyer 10%-Owner Buy 1,000,000 $27.00 $27,000,000 No
2020-10-30 SVB FINANCIAL GROUP 10%-Owner Sell 2,164,515 $25.52 $55,227,600 Yes
2020-10-30 Capital Partners III, L.P. 10%-Owner Sell 1,254,025 $25.52 $31,996,448 Yes
2020-10-30 Venture Overage Fund, L.P. 10%-Owner Sell 312,530 $25.52 $7,974,203 Yes

Insider Smart

SYSCO CORP (SYY) - PELTZ NELSON and Frank Joshua D are insiders of SYSCO CORP, check their transactions to see how they sell high and buy low. Would that be more persuasive than just buy or sell?

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.